Course description
Many western countries have begun to orient their foreign and trade policies around the Indo-Pacific, meaning that the Comprehensive and Progressive Trans-Pacific Partnership (‘CPTPP’) is taking on a new significance. Given that the UK has applied to join the CPTPP, now is the time to assess the rigorous patent protection that will be required once it does, especially in the pharmaceutical, biotech and telecoms sectors.
Patent lawyer Dr Paul England presents this concise and informative webinar which will examine the CPTPP in the particular context of the UK and what the treaty says about patent rights, including the potential impact the CPTPP could have on future patient office cooperation.
Upcoming start dates
Outcome / Qualification etc.
Training Course Content
Introduction
As a number of western countries realign their foreign and trade policies around the Indo-Pacific, the Comprehensive and Progressive Trans-Pacific Partnership (‘CPTPP’), is taking on new significance.
This is particularly so for the UK, which has applied to join the CPTPP.
And, where there is close trade between countries, there is also the need for rigorous patent protection, especially in the pharmaceutical, biotech and telecoms sectors.
This short webinar examines the CPTPP in the particular context of the UK and what the treaty says about patent rights.
What You Will Learn
This webinar will cover the following:
- The general background to the CPTPP
- The reasons for the UK's interest in the CPTPP
- What the CPTPP says about patents
- Potential problems for the UK in respect of patent matters
- The potential impact of the CPTPP on future patent office cooperation
Expenses
MBL Seminars Limited
MBL is a leading learning and development provider for professional service firms. Over the past 18 years, more than 198,000 people across 23,000 different organisations spanning 81 countries, have chosen us to deliver their training. With over 800 expert speakers...